Loading...
Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy
BACKGROUND: Chemotherapy with docetaxel (Doc) remains the standard treatment for metastatic and castration-resistance prostate cancer (CRPC). However, the clinical success of Doc is limited by its chemoresistance and side effects. This study investigated whether natural products green tea (GT) and q...
Na minha lista:
| Udgivet i: | J Exp Clin Cancer Res |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4858851/ https://ncbi.nlm.nih.gov/pubmed/27151407 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-016-0351-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|